Dr. Benedetti Brings More Than 20 Years in Oncology Clinical Development and Global Large Pharma Experience ImmunityBio, Inc., a privately-held immunotherapy company, today announced that it has appointed Fabio M. Benedetti, M.D., as Chief Strategy Officer, effective January 4, 2021. Dr. Benedetti brings more than 20 years of biotech and large pharma experience in oncology clinical development and medical...
Read Full StoryRelated
, 4min
0
Disease-prevention-and-treatment
Linn County Hospital can’t verify age before an appointment for a COIVD-19 vaccine is made
, 8min
0